These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 10810335)

  • 1. Association between the level of ERCC-1 expression and the repair of cisplatin-induced DNA damage in human ovarian cancer cells.
    Li Q; Yu JJ; Mu C; Yunmbam MK; Slavsky D; Cross CL; Bostick-Bruton F; Reed E
    Anticancer Res; 2000; 20(2A):645-52. PubMed ID: 10810335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of interleukin-1 alpha and tumour necrosis factor-alpha on cisplatin-induced ERCC-1 mRNA expression in a human ovarian carcinoma cell line.
    Li Q; Bostick-Bruton F; Reed E
    Anticancer Res; 1998; 18(4A):2283-7. PubMed ID: 9703867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactacystin enhances cisplatin sensitivity in resistant human ovarian cancer cell lines via inhibition of DNA repair and ERCC-1 expression.
    Li QQ; Yunmbam MK; Zhong X; Yu JJ; Mimnaugh EG; Neckers L; Reed E
    Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL61-72. PubMed ID: 11936875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteasome inhibition suppresses cisplatin-dependent ERCC-1 mRNA expression in human ovarian tumor cells.
    Li QQ; Ding L; Reed E
    Res Commun Mol Pathol Pharmacol; 2000; 107(5-6):387-96. PubMed ID: 11589365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines.
    Selvakumaran M; Pisarcik DA; Bao R; Yeung AT; Hamilton TC
    Cancer Res; 2003 Mar; 63(6):1311-6. PubMed ID: 12649192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of DNA repair gene expression in human cancer cell lines.
    McGurk CJ; Cummings M; Köberle B; Hartley JA; Oliver RT; Masters JR
    J Cell Biochem; 2006 Apr; 97(5):1121-36. PubMed ID: 16315315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro studies on the mechanisms of oxaliplatin resistance.
    Hector S; Bolanowska-Higdon W; Zdanowicz J; Hitt S; Pendyala L
    Cancer Chemother Pharmacol; 2001 Nov; 48(5):398-406. PubMed ID: 11761458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by 5-fluorouracil of ERCC1 and gamma-glutamylcysteine synthetase messenger RNA expression in a cisplatin-resistant HST-1 human squamous carcinoma cell line.
    Fujishima H; Nakano S; Masumoto N; Esaki T; Tatsumoto T; Kondo T; Niho Y
    Oncol Res; 1997; 9(4):167-72. PubMed ID: 9268987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines.
    Mamenta EL; Poma EE; Kaufmann WK; Delmastro DA; Grady HL; Chaney SG
    Cancer Res; 1994 Jul; 54(13):3500-5. PubMed ID: 8012973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ERCC-1 overexpression on sensitivity of Chinese hamster ovary cells to DNA damaging agents.
    Bramson J; Panasci LC
    Cancer Res; 1993 Jul; 53(14):3237-40. PubMed ID: 8324733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between platinum-DNA adduct formation and removal and cisplatin cytotoxicity in cisplatin-sensitive and -resistant human ovarian cancer cells.
    Johnson SW; Swiggard PA; Handel LM; Brennan JM; Godwin AK; Ozols RF; Hamilton TC
    Cancer Res; 1994 Nov; 54(22):5911-6. PubMed ID: 7954422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin induction of ERCC-1 mRNA expression in A2780/CP70 human ovarian cancer cells.
    Li Q; Gardner K; Zhang L; Tsang B; Bostick-Bruton F; Reed E
    J Biol Chem; 1998 Sep; 273(36):23419-25. PubMed ID: 9722577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two human ovarian carcinoma cell lines (A2780/CP70 and MCAS) that are equally resistant to platinum, but differ at codon 118 of the ERCC1 gene.
    Yu JJ; Lee KB; Mu C; Li Q; Abernathy TV; Bostick-Bruton F; Reed E
    Int J Oncol; 2000 Mar; 16(3):555-60. PubMed ID: 10675489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of excision repair cross complementation group 1 (ERCC-1) mRNA expression by pharmacological agents in human ovarian carcinoma cells.
    Li Q; Tsang B; Bostick-Bruton F; Reed E
    Biochem Pharmacol; 1999 Feb; 57(4):347-53. PubMed ID: 9933022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin-induced alterations in the expression of the mRNAs for UV-damage recognition protein.
    Vaisman A; Keeney S; Nichols AF; Linn S; Chaney SG
    Oncol Res; 1996; 8(1):7-12. PubMed ID: 8704286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MAPK dependence of DNA damage repair: ionizing radiation and the induction of expression of the DNA repair genes XRCC1 and ERCC1 in DU145 human prostate carcinoma cells in a MEK1/2 dependent fashion.
    Yacoub A; Park JS; Qiao L; Dent P; Hagan MP
    Int J Radiat Biol; 2001 Oct; 77(10):1067-78. PubMed ID: 11682011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Enhanced cisplatin cytotoxicity by RNA interfering the excision repair cross-complementing 1 gene in ovarian cancer cell lines].
    Liu GY; Qu QX; Mi RR; Qi J
    Zhonghua Fu Chan Ke Za Zhi; 2006 May; 41(5):339-42. PubMed ID: 16762192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.
    Zhang Y; Wang J; Xiang D; Wang D; Xin X
    Int J Oncol; 2009 Nov; 35(5):1069-79. PubMed ID: 19787261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on the expression of DNA excision repair biomarkers in cispatin-treated lung cancer cell line].
    Wang ZY; Zhou S; Lu B; Zhang X; Hao QL; Zhou YK
    Zhonghua Yu Fang Yi Xue Za Zhi; 2003 Mar; 37(2):109-11. PubMed ID: 12839662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small interfering RNA-induced suppression of ERCC1 enhances sensitivity of human cancer cells to cisplatin.
    Chang IY; Kim MH; Kim HB; Lee DY; Kim SH; Kim HY; You HJ
    Biochem Biophys Res Commun; 2005 Feb; 327(1):225-33. PubMed ID: 15629453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.